Chiral chromatographic separation
Chiral chromatography is most commonly used in separating enantiomers of racemate compounds for drugs because of its high productivity at low cost. Chiral chromatography using simulated moving-bed system has been installed in most of the major pharmaceutical companies, some of which has processed up to 200 tons per year. Very pure compounds can be obtained by direct crystallization after chiral chromatography has been completed in ninety percent of the cases. In August 2003, an enantiomer of an antidepressant drug was approved by the Food & Drug Administration, making it the first drug produced by this technology to be approved.
As stated in previous posts, the amount of chiral drugs produced each year is increasing at a significant rate. This system is less expensive because of the less time it takes to develop, and the traditional methods cost about two to five times more than the simulated moving-bed system. If chiral chromatography is installed continuously at this rate, the pharmaceutical industry is expected to produce 1,200 metric tons per year of single isomer drugs.
